Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
abx412175-1mg |
Abbexa |
1 mg |
EUR 610.8 |
|
Human IgG antibody Laboratories manufactures the spike glycoprotein gp120 reagents distributed by Genprice. The Spike Glycoprotein Gp120 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact . Other Spike products are available in stock. Specificity: Spike Category: Glycoprotein Group: Gp120
gp120 Antibody |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
gp120 Antibody |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
gp120 Antibody |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
HIV1 gp120 antibody |
Fitzgerald |
100 ug |
EUR 404.4 |
Description: Monoclonal HIV1 gp120 antibody |
HIV1 gp120 antibody |
Fitzgerald |
100 ug |
EUR 333.6 |
Description: Mouse monoclonal HIV1 gp120 antibody |
HIV1 gp120 antibody |
Fitzgerald |
100 ul |
EUR 975.6 |
Description: Rabbit polyclonal HIV1 gp120 antibody |
HIV1 gp120 antibody |
Fitzgerald |
100 ug |
EUR 826.8 |
Description: Rabbit polyclonal HIV1 gp120 antibody |
Gp120 information
Spike Glycoprotein Polyclonal Antibody, HRP Conjugated |
A57202 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Spike Glycoprotein Polyclonal Antibody, HRP Conjugated |
A56215 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Rabbit anti-COVID-19 Spike glycoprotein Antibody |
DL99721A-100ul |
DL Develop |
100 ul |
EUR 299 |
|
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |
Rabbit anti-COVID-19 Spike glycoprotein Antibody |
DL99721A-50ul |
DL Develop |
50 ul |
EUR 210 |
|
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |
Spike Glycoprotein Polyclonal Antibody, FITC Conjugated |
A57203 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Spike Glycoprotein Polyclonal Antibody, FITC Conjugated |
A56216 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Spike Glycoprotein Polyclonal Antibody, Biotin Conjugated |
A57204 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Spike Glycoprotein Polyclonal Antibody, Biotin Conjugated |
A56217 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Recombinant Novel Coronavirus Spike Glycoprotein(S), Partial |
E80018 |
EpiGentek |
-
EUR 388.30
-
EUR 860.20
-
EUR 4888.40
|
|
SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) |
BSV-COV-PR-26 |
BioServUK |
100 ug |
Ask for price |
Description: SARS-CoV-2 Spike Glycoprotein (S1), Sheep (Fc-Tag) (HEK293) |
SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) |
BSV-COV-PR-27 |
BioServUK |
500 ug |
Ask for price |
Description: SARS-CoV-2 Spike Glycoprotein (S1), Sheep (Fc-Tag) (HEK293) |
Infectious bronchitis virus Spike glycoprotein S1 subunit (S1) |
1-CSB-RP182154v |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Infectious bronchitis virus Spike glycoprotein S1 subunit(S1),partial expressed in E.coli |
Recombinant Human Spike glycoprotein Protein, His, Yeast-1mg |
QP7178-ye-1mg |
EnQuireBio |
1mg |
EUR 2262 |
SARS-CoV-2 Spike Glycoprotein (S1), His-Tag (Insect Cells) |
BSV-COV-PR-24 |
BioServUK |
100 ug |
Ask for price |
Description: SARS-CoV-2 Spike Glycoprotein (S1), (His-Tag) (Insect Cells) (Spike Protein (S1)) |
SARS-CoV-2 Spike Glycoprotein (S1), His-Tag (Insect Cells) |
BSV-COV-PR-25 |
BioServUK |
500 ug |
Ask for price |
Description: SARS-CoV-2 Spike Glycoprotein (S1), (His-Tag) (Insect Cells) (Spike Protein (S1)) |
Recombinant Human Spike glycoprotein Protein, His, Yeast-10ug |
QP7178-ye-10ug |
EnQuireBio |
10ug |
EUR 283.2 |
Recombinant Human Spike glycoprotein Protein, His, Yeast-50ug |
QP7178-ye-50ug |
EnQuireBio |
50ug |
EUR 358.8 |